Technology
Optimising eDNA
Precision and Innovation
Environmental DNA (eDNA) is rapidly transforming how we monitor and understand microbial life, and we’re at the forefront of leveraging this powerful tool to build a healthier world. At Resistomap, our eDNA analysis services are built on high-throughput quantitative PCR (HT-qPCR) technology—a choice driven by two critical advantages: its exceptional quality and precision, combined with the ability to generate high-throughput, quantifiable data suitable for time-series analysis.
As antimicrobial resistance (AMR) continues to pose a serious global challenge, eDNA is emerging as an essential tool in confronting it. On this page, you can get a glimpse into how we utilise advanced molecular technology to harness eDNA, delivering the most comprehensive AMR monitoring service available today.
At the core
The high-throughput qPCR method
The workhorse of our service is HT-qPCR technology, a method designed to quantify genes with both precision and efficiency. This high-throughput approach allows us to screen hundreds of targets simultaneously, detecting ARGs even at low abundance within complex environmental samples.
Unlike standard qPCR, HT-qPCR uses an array-based format that with high sensitivity and specificity is able to quantify multiple genes across hundreds of samples in parallel. This technology is particularly valuable for AMR monitoring, as it captures data at the necessary depth to track resistance gene shifts over time, revealing shifts in trends. By providing quantifiable, reproducible results, HT-qPCR gives our customers the data needed to make accurate risk assessments, contributing to an informed response to AMR in a range of settings, from wastewater to clinical environments.
Find out more about the technology at TakaraBio's website
Cloud based biosecurity platform
To make the most of the data generated by HT-qPCR analysis, we use our Resistomap Platform—a cloud-based biosecurity intelligence service specifically built for tracking antimicrobial resistance (AMR) in various environments. The platform lets users visualise ARG abundances and gene copy numbers, making it easy to track how these values change over time and across locations.
With features like antibiotic resistance indexes, users can detect long-term trends that support better risk assessment and planning. The Resistomap Platform has broad applications, from monitoring public health and protecting natural environments to evaluating wastewater treatment processes. With customisable assays and the power of high-throughput qPCR, the platform provides both the precision and flexibility researchers need to dive deep into AMR dynamics, helping them analyse patterns and shifts with confidence.
Protocols supported by robotic precision
Our commitment to precision begins with meticulous protocols that set the highest standards for each sample. These protocols are crafted to enhance accuracy and consistency, using automation wherever possible to ensure precise handling.
Robotics manage key tasks, such as pipetting primers and handling dilutions, so each sample is processed uniformly for highly reproducible results. Additionally, we use spectrophotometry to assess DNA quality and concentration, further supporting data reliability.
For a closer look at how these auxiliary technologies contribute to our workflow, you can find more information in the section below.
lab processes
Robust monitoring and evaluation are needed in order to measure progress towards the delivery of the Global Action Plan on Antimicrobial Resistance (GAP) objectives, and help identify key achievements and persisting gaps across human, animal, plant, food, and environment sectors in efforts to tackle antimicrobial resistance (AMR).
Monitor antibiotic resistance with our cutting-edge technology
Contact us to see how our biosecurity intelligence platform can benefit your organization
FAQs
Find answers to the most common questions about our monitoring service process, gene selection, DNA concentrations and other important information.
See all FAQsYes, at the moment we have 26 primer sets available to target certain taxonomy group of bacteria and pathogens.
In each chip analysis, we can measure up to 384 genes, including 16S rRNA gene (positive control); antibiotic resistance genes (ARGs) targeting aminoglycoside, amphenicol, beta lactam, florphenicol, multidrug efflux-pump, macrolide-lincosamide-streptogramin B (MLSB), trimethoprim, tetracycline, vancomycin; genes targeting other antibacterials such as nisin, bacitracin, antiseptic, mercury; and genes that are associated with mobile genetic elements (MGEs) and integrons.
Yes, you can customise the target genes with an extra customisation fee. The customisation options for chip analysis are:
- 296 Genes: 5 Samples;
- 248 Genes: 6 Samples;
- 216 Genes: 8 Samples;
- 144 Genes: 12 Samples;
- 120 Genes: 14 Samples;
- 96 Genes: 18 Samples;
- 80 Genes: 21 Samples;
- 72 Genes: 24 Samples;
- 54 Genes: 32 Samples;
- 48 Genes: 36 Samples;
- 36 Genes: 48 Samples;
- 24 Genes: 72 Samples;
- 12 Genes: 128 Samples;
- and 6 Genes: 256 Samples.
You can choose the target genes based on over 600 previously validated primer sets that are available in our database from the the ARG selection sheet that we will send you separately.
In Resistomap we provide antibiotic resistance monitoring services starting from sampling to the final analysis of the SmartChip qPCR results.
We deliver analysis results within 10 working days. For three or more chips, the analysis process may take longer.
We accept all types of samples, e.g., soil, sediment, sludge, manure, stool, meat, tissue, swabs, river, lake, wastewater, and seawater.